Amneal Pharmaceuticals, Inc. provided earnings guidance for the full year of 2022. For the year, the company expects net revenue to be between $2.15 billion to $2.25 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.745 USD | -0.07% | +1.35% | +11.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.20% | 2.08B | |
+32.07% | 694B | |
+29.39% | 593B | |
-1.75% | 371B | |
+19.95% | 331B | |
+6.87% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+7.93% | 169B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year of 2022